Nombre del producto:(2R,3R,4R,5S,6R)-6-(Hydroxymethyl)-3-((7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino)tetrahydro-2H-pyran-2,4,5-triol

IUPAC Name:(2R,3R,4R,5S,6R)-6-(hydroxymethyl)-3-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]oxane-2,4,5-triol

CAS:174844-42-9
Fórmula molecular:C12H14N4O8
Pureza:95%
Número de catálogo:CM155229
Peso molecular:342.26

Unidad de embalaje Stock disponible Precio($) Cantidad

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :174844-42-9
Fórmula molecular:C12H14N4O8
Punto de fusión:-
Código de sonrisas:O[C@H]1[C@H](NC2=CC=C([N+]([O-])=O)C3=NON=C32)[C@H]([C@@H]([C@@H](CO)O1)O)O
Densidad:
Número de catálogo:CM155229
Peso molecular:342.26
Punto de ebullición:
Nº Mdl:MFCD20527306
Almacenamiento:Store at 2-8°C.

Category Infos

Benzofurazans
Benzofurazans are important pharmaceutical intermediates. Benzofurazans are known bioisosteres of the nitro group. Both oxadiazoles and nitro groups have strong electron-withdrawing properties, but when optimizing drug-like properties such as activity, selectivity, and stability, the absence of standard charges in the oxadiazole structure may be more beneficial to drug products. What's more, nitro groups have been identified as toxic groups, and it is routine to remove or replace them in the early stages of drug development.